Komori
Share Issuance and Disposal4563AnGes,Inc.Pharmaceuticals

Notice of Completion of Payment for the Third-Party Allotment of the 47th Stock Acquisition Rights (with an Exercise Price Adjustment Clause), the 48th Stock Acquisition Rights and the 2nd Unsecured Convertible Bonds with Stock Acquisition Rights

Payment for the third-party allotment of the 47th and 48th Stock Acquisition Rights and the 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights, as resolved on 14 August 2026, has been completed.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
8500000000
Yen (total funds raised)
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Issuance of the 47th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment, Issuance of the 48th Stock Acquisition Rights through a third-party allotment, Issuance of the second series of unsecured convertible bonds with stock acquisition rights through a private placement

Who receives how much

47th Stock Acquisition Rights: 79,633,700 potential shares; 48th Stock Acquisition Rights: 57,365,800 potential shares; 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights: 45,977,011 potential shares

GP Fund (796,337 47th Stock Acquisition Rights, 573,658 48th Stock Acquisition Rights and 40 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights)

The lower thin line represents the existing number of shares to which these shares will be added.

47th Stock Acquisition Rights: ¥23 per right, 48th Stock Acquisition Rights: ¥8 per right, Convertible bonds with stock acquisition rights: ¥100 per ¥100 of bond principal; the stock acquisition rights are issued free of charge
Total issue value

47th Stock Acquisition Rights: ¥18,315,751, 48th Stock Acquisition Rights: ¥4,589,264, Convertible bonds with stock acquisition rights: ¥2,000,000,000

Amount of funds to be raised
47th Stock Acquisition Rights: ¥4,000,000,751 in total; estimated net proceeds of ¥3,843,279,281, 48th Stock Acquisition Rights: ¥2,500,001,564 in total; estimated net proceeds of ¥2,352,852,464, Convertible bonds with stock acquisition rights: ¥2,000,000,000 in total
Terms of the stock acquisition rights
Exercise price
47th Stock Acquisition Rights: initially ¥50.0, adjusted to 90% of the closing price on the immediately preceding trading day, with a floor of ¥25.0 and no ceiling. 48th Stock Acquisition Rights: ¥43.5, with no adjustment. Convertible bonds with stock acquisition rights: conversion price of ¥43.5, with no adjustment
Exercise period
47th and 48th Stock Acquisition Rights: from 1 September 2026 to 31 August 2031. Conversion period for the convertible bonds with stock acquisition rights: from 1 September 2026 to 31 August 2031
Number of Stock Acquisition Rights
47th: 796,337 rights; 48th: 573,658 rights. Remaining unexercised rights: Not disclosed
Payment date
31 August 2026
Procedures under the Corporate Code of Conduct
In accordance with Article 434, Paragraph 1 of the Tokyo Stock Exchange Securities Listing Regulations and Article 436, Paragraphs 1 through 5 of the Enforcement Rules for the Regulations, an exercise volume restriction will be imposed on the 47th Stock Acquisition Rights
Most recent equity financing
Resolution dated 14 August 2026: issuance through a third-party allotment of the 47th Stock Acquisition Rights, the 48th Stock Acquisition Rights and the 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights (referenced in this document)
Details of issuance or disposal
ItemDetails
Type of issuance or disposalIssuance of the 47th Stock Acquisition Rights (with Exercise Price Adjustment Clause) through a third-party allotment, Issuance of the 48th Stock Acquisition Rights through a third-party allotment, Issuance of the second series of unsecured convertible bonds with stock acquisition rights through a private placement
Number of shares to be issued or disposed of47th Stock Acquisition Rights: 79,633,700 potential shares; 48th Stock Acquisition Rights: 57,365,800 potential shares; 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights: 45,977,011 potential shares
Issue price and disposal price47th Stock Acquisition Rights: ¥23 per right, 48th Stock Acquisition Rights: ¥8 per right, Convertible bonds with stock acquisition rights: ¥100 per ¥100 of bond principal; the stock acquisition rights are issued free of charge
Total issue value47th Stock Acquisition Rights: ¥18,315,751, 48th Stock Acquisition Rights: ¥4,589,264, Convertible bonds with stock acquisition rights: ¥2,000,000,000
Amount of funds to be raised47th Stock Acquisition Rights: ¥4,000,000,751 in total; estimated net proceeds of ¥3,843,279,281, 48th Stock Acquisition Rights: ¥2,500,001,564 in total; estimated net proceeds of ¥2,352,852,464, Convertible bonds with stock acquisition rights: ¥2,000,000,000 in total
Payment date31 August 2026
Intended allotteeGP Fund (796,337 47th Stock Acquisition Rights, 573,658 48th Stock Acquisition Rights and 40 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights)
Exercise price47th Stock Acquisition Rights: initially ¥50.0, adjusted to 90% of the closing price on the immediately preceding trading day, with a floor of ¥25.0 and no ceiling. 48th Stock Acquisition Rights: ¥43.5, with no adjustment. Convertible bonds with stock acquisition rights: conversion price of ¥43.5, with no adjustment
Exercise period47th and 48th Stock Acquisition Rights: from 1 September 2026 to 31 August 2031. Conversion period for the convertible bonds with stock acquisition rights: from 1 September 2026 to 31 August 2031
Number of Stock Acquisition Rights47th: 796,337 rights; 48th: 573,658 rights. Remaining unexercised rights: Not disclosed
Procedures under the Corporate Code of ConductIn accordance with Article 434, Paragraph 1 of the Tokyo Stock Exchange Securities Listing Regulations and Article 436, Paragraphs 1 through 5 of the Enforcement Rules for the Regulations, an exercise volume restriction will be imposed on the 47th Stock Acquisition Rights
Most recent equity financingResolution dated 14 August 2026: issuance through a third-party allotment of the 47th Stock Acquisition Rights, the 48th Stock Acquisition Rights and the 2nd Series Unsecured Convertible Bonds with Stock Acquisition Rights (referenced in this document)
Items this document does not state (16)
Estimated issuance expensesSpecific use of fundsIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company stated that it had confirmed completion of payment for the securities issued, as resolved at the Board of Directors meeting held on 14 August 2026. The document does not state the use of proceeds or purpose of the issuance.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of Completion of Payment for the Third-Party Allotment of the 47th Stock Acquisition Rights (with an Exercise Price Adjustment Clause), the 48th Stock Acquisition Rights and the 2nd Unsecured Convertible Bonds with Stock Acquisition Rights | AnGes,Inc. (4563) timely disclosure | Komori